The present invention relates to a human neural stern cell, and to a pharmaceutical composition for the treatment of central or peripheral nervous system disorders and injuries using same. More particularly, the present invention relates to a human telencephalon-derived human neural stem cell effective in the treatment of nervous system disorders and injuries, and to a pharmaceutical composition for the treatment of nervous system disorders and injuries using same, to the use of the human neural stem cell for preparing therapeutic agents for the treatment of nervous system disorders and injuries, and to a method for treating nervous system disorders and injuries, capable of administrating an effective amount of the human neural stem cells into individuals that need the human neural stem cells. The human neural stem cell of the present invention has active effects for treating patients of neural system disorders and injuries, specifically for treating patients with a severe spinal cord injury, ischemic brain damage, epilepsy, and Alzheimer's disease, known to have no special treatment as of present and remain with permanent neurological aftereffects. Accordingly, the pharmaceutical composition containing the human neural stem cell of the present invention provides a novel method for treating neural system injuries.본 발명은 인간 신경줄기세포 및 이를 이용한 신경계 질환 및 손상 치료용 약학적 조성물에 관한 것이다. 보다 상세하게는, 본 발명은 신경계 질환 및 손상의 치료에 효과적인 인간 종뇌 유래 인간 신경줄기세포 및 이를 이용한 신경계 질환 및 손상 치료용 약학적 조성물에 관한 것이다. 본 발명의 인간 신경줄기세포는 신경계 질환 및 손상, 특히 현재 특별한 치료법이 없으며 영구적 신경학적 후유증을 남기는 중증 척수 손상 환자, 허혈성 뇌손상, 간질 및 알쯔하이머병의 치료에 유효한 효과를 가진다. 따라서, 본 발명의 인간 신경줄기세포를 포함하는 약학적 조성물은 신경계 손상의 치료를 위한 새로운 방법을 제공하는 효과가 있다.
